Basic Information
Basic information for SNHG11-229-11aa-4
Peptide Name SNHG11-229-11aa-4
Genome Position chr20:38450445-38450447,38450533-38450562[+]
Species Human
Peptide Sequence MIVWGLITDQE
Peptide Length 11
Unique No (SNHG11-201-11aa,SNHG11-202-11aa,SNHG11-203-11aa,SNHG11-205-11aa,SNHG11-206-11aa,SNHG11-207-11aa,SNHG11-209-11aa,SNHG11-211-11aa-2,SNHG11-212-11aa,SNHG11-214-11aa,SNHG11-215-11aa,SNHG11-217-11aa-2,SNHG11-218-11aa,SNHG11-219-11aa,SNHG11-220-11aa,SNHG11-221-11aa,SNHG11-222-11aa-2,SNHG11-223-11aa-1,SNHG11-224-11aa,SNHG11-225-11aa,SNHG11-227-11aa,SNHG11-230-11aa,SNHG11-231-11aa,SNHG11-233-11aa,SNHG11-234-11aa,SNHG11-235-11aa,SNHG11-237-11aa-3)
Grand Average of Hydropathicity 0.5818
Relative Molecular Mass 1484.7
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000174365;SNHG11
Transcript ID/Name ENST00000663763;SNHG11-229
Transcript Length 4108
Coding Ability 0.4056
DNA Sequence Corresponding to Peptide ATGATTGTTTGGGGGTTGATCACAGACCAAGAG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :